Monoamine oxidase inhibitions are considered as important targets for the treatment of depression, anxiety, and neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. This has encouraged many medicinal chemistry research groups for the development of most promising selective monoamine oxidase (MAO) inhibitors. A large number of plant isolates also reported for significant MAO inhibition potential in recent years. Differently substituted flavonoids have been prepared and investigated as MAO-A and MAO-B inhibitors. Flavonoid scaffold showed notable antidepressant and neuroprotective properties as revealed by various and established preclinical trials. The current review made an attempt to summarizing and critically evaluating the new findings on the quercetin and related flavonoid derivatives functions as potent MAO isoform inhibitors.
It is clear that, by this computational drug design approach, more particular, reversible and potent compounds can be proposed as MAO inhibitors by exact changes on the fundamental framework.
Natural based inhibitors of monoamine oxidase are promising drug candidates for the treatment of several neurodegenerative and neuropsychological disorders including depression, anxiety, Parkinson’s disease and Alzheimer’s disease. In the present study we designed and synthesized the eugenol based derivatives and investigated them for human MAO inhibitory potential as promising candidates for therapeutics of neurological disorders. Moreover, radical scavenging activity of designed derivatives was tested by and H
2
O
2
and DPPH scavenging methods. Eugenol based derivatives were designed and synthesized for human MAO inhibitory action. The in silico and in vitro models were utilized for the evaluation of hMAO inhibition. The insight into molecular interactions among the compounds and both hMAO-A and hMAO-B active site was achieved by molecular docking studies. The two spectrophotometric titrations techniques were used to evaluate antioxidant potential. Compounds
5b
and
16
were found as most active hMAO-A inhibitors with IC
50
values of 5.989 ± 0.007 µM and 7.348 ± 0.027 µM respectively, through an appreciable selectivity index value of 0.19 and 0.14 respectively. In case of hMAO-B inhibition compounds
13a
and
13b
were found as most active hMAO-B inhibitors with IC
50
values of 7.494 ± 0.014 µM and 9.183 ± 0.034 µM receptively and outstanding value of selectivity index of 5.14 and 5.72 respectively. Radical scavenging assay showed that compounds
5b
,
5a
,
9b
,
9a
were active antioxidants. The findings of present study indicated excellent correlation among dry lab and wet lab hMAO inhibitory experiments. Interestingly, the compounds exhibiting better MAO inhibition activity was also appeared as good antioxidant agents.
<P>Background: A large number of disorders and their symptoms emerge from deficiency or
overproduction of specific metabolites has drawn the attention for the discovery of new therapeutic
agents for the treatment of disorders. Various approaches such as computational drug design have provided
the new methodology for the selection and evaluation of target protein and the lead compound
mechanistically. For instance, the overproduction of xanthine oxidase causes the accumulation of uric
acid which can prompt gout.
</P><P>
Objective: In the present study we critically discussed the various techniques such as 3-D QSAR and
molecular docking for the study of the natural based xanthine oxidase inhibitors with their mechanistic
insight into the interaction of xanthine oxidase and various natural leads.
Conclusion:
The computational studies of deferent natural compounds were discussed as a result the
flavonoids, anthraquinones, xanthones shown the remarkable inhibitory potential for xanthine oxidase
inhibition moreover the flavonoids such as hesperidin and rutin were found as promising candidates for
further exploration.<P>
The development of xanthine oxidase and monoamine oxidase inhibitors led to important
breakthroughs in the therapy of oxidative damage, hyperuricemia, gout, neurological, neuropsychiatric
disorders and management of reperfusion injury. Drugs obtained from natural sources play an important
role in the treatment of various pathological disorders and act as a lead compound for the discovery of
new synthetic drug substances. In this review, various pharmacological effects produced by the inhibition
of xanthine oxidase and monoamine oxidase through natural and synthetic flavonoids as well as
anthraquinones are discussed in detail. Several methods have been designed for monitoring enzymatic
activity and its inhibitor screening of bioactive natural and synthetic flavonoids and anthraquinones. In
this review, all the in-vitro and other computational approaches are critically discussed which provided
the clue about structure activity requirements for further precise modifications on the basic scaffold.
Two new series of methyl 7-methyl-5-(substituted-phenyl)-3,5-dihydro-2H-substituted [3,2-a]pyrimidine-6-carboxylate derivatives of thiourea and guanidine were synthesized. These compounds were characterized and evaluated for their antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and antifungal Aspergillus niger and Candida albicans and free radical scavenging activity using DPPH reagent method. Compound 7f was found to be the most active antibacterial and antifungal agent comparable to the standard drugs ciprofloxacin and fluconazole. Further, the compounds 5e, 7g, and 7h were also found to have significant antimicrobial activity. Compound 5a was found to be the most active antioxidant among all the targeted compounds, while compounds 5b, 5g, 7b, and 7f also had significant antioxidant activity compared to standard ascorbic acid.
Background
Xanthine oxidase is an important enzyme of purine catabolism pathway and has been associated directly in pathogenesis of gout and indirectly in many pathological conditions like cancer, diabetes and metabolic syndrome. In this research rutin, a bioactive flavonoid was explored to determine the capability of itself and its derivatives to inhibit xanthine oxidase.
Objective
To develop new xanthine oxidase inhibitors from natural constituents along with antioxidant potential.
Method
In this report, we designed and synthesized rutin derivatives hybridized with hydrazines to form hydrazides and natural acids to form ester linkage with the help of molecular docking. The synthesized compounds were evaluated for their antioxidant and xanthine oxidase inhibitory potential.
Results
The enzyme kinetic studies performed on rutin derivatives showed a potential inhibitory effect on XO ability in competitive manner with IC
50
value ranging from 04.708 to 19.377 µM and
RU3a
3
was revealed as most active derivative. Molecular simulation revealed that new rutin derivatives interacted with the amino acid residues PHE798, GLN1194, ARG912, GLN 767, ALA1078 and MET1038 positioned inside the binding site of XO. Results of antioxidant activity revealed that all the derivatives showed very good antioxidant potential.
Conclusion
Taking advantage of molecular docking, this hybridization of two natural constituent could lead to desirable xanthine oxidase inhibitors with improved activity.
Electronic supplementary material
The online version of this article (10.1186/s13065-019-0585-8) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.